Kuwait City: The Ministry of Health (MoH)declared the issuance of licenses for emergency use of the medicine Sotrovimab(7831-VIR) for treating light and medium intensity COVID-19 cases.
The assistant undersecretary for medicinesand nutrition supervision, Dr. Abdullah Al-Badr reported that the medication isused for such cases among adults and children aged 12 and above.
He also indicated that the medicine is usedfor persons of 65 years of age and above, but not for hospitalized patients whoneed oxygen due to infection with COVID-19. This medicine has lowered hospitaladmissions and deaths by 85 percent as per the clinical studies. He added thatthis medicine prevents the virus from creeping into human cells.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?